And while other options exist like dry-powder inhalers and soft mist inhalers, MDIs are still the best option for many patients for a variety of reasons, according to AstraZeneca. AstraZeneca and ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

After hours: December 16 at 5:28:23 PM EST Loading Chart for AMPH ...